awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34438769-29521A6D-9B87-46FA-93C6-D53CB895D865
Q34438769-29521A6D-9B87-46FA-93C6-D53CB895D865
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34438769-29521A6D-9B87-46FA-93C6-D53CB895D865
Randomized trial showing efficacy and safety of twice-daily remogliflozin etabonate for the treatment of type 2 diabetes.
P433
Q34438769-29521A6D-9B87-46FA-93C6-D53CB895D865
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34438769-29521A6D-9B87-46FA-93C6-D53CB895D865
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a77ce7724ae5b927158246357eba9e685ef4013
P433
1
http://www.w3.org/2001/XMLSchema#string